Related Experiment Video
Updated: Jun 24, 2026

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
Medical bioremediation of age-related diseases
Jacques M Mathieu1, John Schloendorn, Bruce E Rittmann
1Dept, of Civil and Environmental Engineering, Rice University, Houston, TX, USA. mathieu@rice.edu.
Abstract:
Catabolic insufficiency in humans leads to the gradual accumulation of a number of pathogenic compounds associated with age-related diseases, including atherosclerosis, Alzheimer's disease, and macular degeneration. Removal of these compounds is a widely researched therapeutic option, but the use of antibodies and endogenous human enzymes has failed to produce effective treatments, and may pose risks to cellular homeostasis. Another alternative is "medical bioremediation," the use of microbial enzymes to augment missing catabolic functions. The microbial genetic diversity in most natural environments provides a resource that can be mined for enzymes capable of degrading just about any energy-rich organic compound. This review discusses targets for biodegradation, the identification of candidate microbial enzymes, and enzyme-delivery methods.
Insights
Medical bioremediation uses microbial enzymes to remove harmful compounds that accumulate in aging and cause diseases like Alzheimer's. This approach offers a promising alternative to traditional therapies for age-related conditions.
Area of Science:
- Biochemistry
- Microbiology
- Biotechnology
Background:
- Catabolic insufficiency in humans causes pathogenic compound accumulation, linked to age-related diseases such as atherosclerosis and Alzheimer's disease.
- Current therapeutic strategies, including antibodies and endogenous human enzymes, have shown limited efficacy and potential risks to cellular homeostasis.
- Medical bioremediation presents an alternative strategy by leveraging microbial enzymes to restore catabolic functions.
Purpose of the Study:
- This review explores the potential of medical bioremediation for treating age-related diseases.
- It identifies specific targets for biodegradation and suitable microbial enzymes.
- The review also discusses effective enzyme delivery methods for therapeutic applications.
Main Methods:
- The review synthesizes existing research on catabolic pathways and age-related disease mechanisms.
- It analyzes the microbial genetic diversity for identifying enzymes with specific degradation capabilities.
- Methods for enzyme delivery, including potential delivery vectors and strategies, are discussed.
Main Results:
- Microbial enzymes offer a diverse enzymatic toolkit for degrading a wide range of organic compounds.
- Specific microbial enzymes can be identified and engineered to target pathogenic compounds associated with age-related diseases.
- Various enzyme delivery systems are being explored to ensure targeted and effective delivery within the human body.
Conclusions:
- Medical bioremediation, utilizing microbial enzymes, represents a promising therapeutic avenue for managing age-related diseases.
- Further research into enzyme discovery, engineering, and delivery systems is crucial for clinical translation.
- This approach holds potential for augmenting human catabolic functions and mitigating disease progression.
Related Concept Videos
Bioremediation
Microbial Bioremediation of Hydrocarbons
Microbial Bioremediation of Pesticides
Microbial Bioremediation of Uranium
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Bioavailability: Influencing Factors

